The in vitro production of rosmarinic acid (RA), an ester of caffeic acid and 3,4-dihydroxyphenyllactic acid, has particular importance as it has always been included in important phenolics lists owing to its antioxidant, antiinflammatory, anticancer, and antidiabetic properties, make it attractive in the food industry as well as complementary medicine (Petersen and Simmons, 2003).The organic synthesis of RA is tedious, time-consuming, and costly (Chapado et al., 2010;Brahmachari, 2013). Therefore, producers still rely on natural sources in terms of RA supply and recently in vitro grown plantlets have become more promising (Su et al., 1995;Chapado et al., 2010). The first successful in vitro production of rosmarinic acid was achieved by using cell cultures of Coleus blumei Benth. (Razzaque and Ellis, 1977;Zenk et al., 1977). They successfully produced RA in vitro at 21% (w/w) as dry weight base. Afterwards, many researchers contributed to the accumulation of information concerning RA production in vitro (e.g., Ulbrich et. al., 1985;Pavlov et al.,